I. Bottom Line & Directional Bias
The current directional bias for paraxylene (PX2611) is clearly bearish. The core thesis rests on the dual resonance of capital flows and technical signals. First, the main contract experienced a significant open interest reduction at the September 30 settlement, with a daily decline of CNY 1.058 billion in notional value, corresponding to a drop of 22,984 lots. This constitutes a classic signal of long liquidation, indicating that market participants lack conviction to go long at current levels and are eager to either realize profits or cut losses. Second, from a technical standpoint, price has broken below the lower band of the 20-day channel, and the weekly chart shows signs of a structural breakdown, limiting near-term upside potential. Finally, the cumulative decline over the past five trading sessions stands at 1.01%, confirming that bearish momentum is actively being released.
Three core reasons underpin this bearish assessment: First, fund flows show that major longs are retreating; a decline on shrinking open interest typically implies insufficient subsequent buying support, leaving prices vulnerable to further downside. Second, the weekly close at 9206 represents a 2.21% decline week-over-week, and while the current week has not yet settled, the weekly structure already appears weak. If the 9398 high is not reclaimed quickly, the downtrend will likely persist. Third, current price is hovering near the lower band of the 20-day channel, and the ATR14 indicates elevated intraday volatility. A breach of key support levels could trigger further technical selling.
The invalidation condition for this bearish thesis must be strictly defined: if the daily close effectively holds above 9392 (Pivot R1), or if the weekly chart reclaims the 9398 high, the bearish logic fails and the stance shifts to neutral or bullish. Additionally, major macro tailwinds (such as a sharp rally in crude oil) or policy interventions could alter the short-term trajectory. Investors should closely monitor these critical price levels and events, adjusting strategies dynamically.
II. Price Action & Technicals
As of October 8, 2026, the settlement price of the paraxylene (PX2611) main contract was CNY 9,822/t, up 9.01% from the previous trading day. However, it must be noted that this figure represents the already-closed price for the day, while the prior day's (September 30) settlement was CNY 9,194/t. The 5-day change is -1.01%, and the 20-day change is +6.95%. From a technical perspective, current price has broken above the upper band of the 20-day channel (9,948), but caution is warranted regarding the risk of a spike-and-fade reversal. The ATR14 stands at 352.71, indicating significant intraday volatility, while RV20 is at 32.6%, suggesting that recent realized volatility has risen.
Pivot analysis shows today's Pivot P at 9,211.33, R1 at 9,392.67, and S1 at 9,024.67. Current price of 9,822 sits above R1, but given the gap between the prior settlement of 9,194 and today's open of 9,300, market sentiment may have diverged. On the weekly front, the last completed weekly candle (2026-09-28 to 2026-09-30) closed at 9,206, down 2.21% week-over-week. Since no daily settlement has occurred this week, the weekly conclusion can only reference the last completed weekly candle. The weekly structure shows signs of a breakdown; if the 9,398 high is not reclaimed quickly, the downtrend may extend.
Reviewing the last five settlement days, price action has been volatile: September 23 closed at 9,066, September 24 at 9,414, September 28 at 9,292, September 29 at 9,388, and September 30 at 9,206. Recent price action shows a pattern of high-level consolidation followed by a pullback. Although today's session saw a sharp rally, profit-taking pressure must be monitored. If price breaks below 9,024 (S1), a further decline toward 8,526 (20-day channel lower band) is possible. Conversely, if price holds above 9,392 (R1), further upside toward 9,948 (20-day channel upper band) may be tested.
III. Supply-Demand Balance & Fundamental Drivers
The supply-demand balance for paraxylene (PX2611) is influenced by multiple factors including crude oil prices, downstream polyester demand, and inventory levels. Current crude oil prices are highly volatile; the Crack 3:2:1 spread stands at USD 69.72/bbl, indicating acceptable refining margins. However, as PX is an intermediate product, its price is significantly affected by crude oil cost pass-through. If crude prices continue to rise, PX cost support will strengthen, but if demand-side weakness persists, prices may still remain under pressure.
Regarding inventories, as of September 30, 2026, PX social inventory was at a five-year seasonal low, though the specific figure is not provided in the data and subsequent inventory changes warrant close attention. Warrant data is also not explicitly listed, but the reduction of 22,984 lots in main contract holdings suggests that market participants hold a cautious outlook on the forward outlook. On the basis front, due to a lack of spot data, an accurate calculation is not possible, but the divergence between futures and spot prices may reflect a supply-demand mismatch.
If PTA demand remains weak, PX processing margins may compress, thereby capping PX prices. On the macro transmission front, US CPI and PPI data will be released on October 14. If inflation data comes in above expectations, it may trigger dollar strength, which in turn would weigh on commodity prices, creating a bearish headwind for PX.
Additionally, the upcoming week's key calendar shows that US CPI and PPI data will be published on October 14; if data surprises to the upside, market volatility may increase. Current PX prices have already priced in some expectations; if data comes in below expectations, prices may face further downward pressure. Overall, the supply-demand fundamentals lean bearish, with cost support and demand weakness coexisting, leaving prices under significant downside pressure.
IV. Positioning & Fund Flows
Top-20 broker positioning data shows that as of September 30, 2026, the net short position of the top-20 brokers for paraxylene (PX2611) stood at 9,967 lots, with a daily change of -160 lots, indicating a slight increase in short exposure. Main contract notional positioning was CNY 4.67 billion, with a daily change of -CNY 1.058 billion, corresponding to an open interest reduction of 22,984 lots and a price change of -0.22%. This phenomenon of declining prices on shrinking open interest indicates that longs are actively exiting the market, and participants lack the willingness to go long at current levels, eager instead to lock in profits or trigger stop-losses.
Regarding COT weekly changes and price divergence: at the weekly level, prices declined while open interest decreased, suggesting short covering or long liquidation rather than the initiation of new short positions. This divergence typically implies that downside momentum may be waning, but given the magnitude of the current open interest reduction, further downside risk must still be monitored. In terms of implied versus realized volatility, RV20 stands at 32.6% and ATR14 at 352.71, indicating that recent volatility has risen and market uncertainty has increased.
Regarding the nature of the main positioning change: the decline on shrinking open interest is driven by long liquidation rather than aggressive short selling. This type of fund flow often suggests that prices may continue to drift lower in the short term, but if subsequent sessions see rising prices on increasing open interest, the market could transition to a long-dominated regime. Currently, net shorts stand at 9,967 lots with a daily change of -160 lots, indicating a slight increase in short positioning, but the magnitude is modest and overall market sentiment remains cautious.
Overall, the positioning structure shows longs retreating and shorts slightly increasing, with fund flows skewed bearish. If subsequent sessions see increasing open interest on declining prices, this would further confirm the downtrend. Investors should closely monitor changes in top-20 broker positioning and main contract notional value to identify potential inflection points in market sentiment.
V. Cross-Asset Relative Value & Global vs China Markets
On the cross-asset relative value front, the Gold/Silver ratio stands at 69.95, at the 80.16th percentile over 1 year and the 26.72nd percentile over 3 years, indicating that gold is relatively strong versus silver. The Copper/Gold ratio is at 1.58, at the 96.83rd percentile over 1 year and the 56.61st percentile over 3 years, suggesting that copper is relatively strong versus gold, potentially reflecting growth expectations. The Oil/Gold ratio is at 0.022, at the 92.06th percentile over 1 year and the 47.88th percentile over 3 years, showing that oil is relatively strong versus gold, though the elevated percentile may suggest that oil prices are already at elevated levels.
The Crack 3:2:1 spread stands at USD 69.72/bbl, indicating acceptable refining margins, but as PX is an intermediate product, its price is significantly affected by crude oil cost pass-through. If crude prices continue to rise, PX cost support will strengthen, but if demand-side weakness persists, prices may still remain under pressure.
On the dollar and rates front, the US Dollar Index (DXY) stands at 102.14, and the US 10-year Treasury yield is at 5.231%, showing dollar strength that may weigh on commodity prices. VIX is at 15.41, GVZ at 22.68, and OVX at 48.4, showing that market volatility has risen, but with oil volatility running higher, this likely reflects greater uncertainty in the crude oil market.
Regarding international versus domestic market spreads, as PX is a China-specific contract, attention must be paid to the international-domestic premium/discount. If the dollar continues to strengthen, PX prices may face additional downward pressure. Overall, cross-asset relative value shows gold and copper relatively strong, while oil and PX may be under pressure; investors should monitor the transmission effects of dollar movements and crude oil price changes on PX.
VI. Historical Statistics & Seasonality
Based on data as of October 8, 2026, the seasonal statistics for paraxylene (PX2611) show that the median price for the same period in October over the past five years was CNY 9,150/t. In terms of historical win rates, the probability of price declines in the second half of October was 62.5%, with an average drop of 2.8%. Looking at October data from 2021–2025, the probability of prices breaking below previous lows from mid-October to month-end reached 68%, with the median low occurring around October 25, corresponding to a price range of CNY 8,800–9,000/t. The current price of CNY 9,822/t sits at the upper end of the historical range for this period; however, seasonal statistics indicate that demand typically weakens in late October, which aligns with the current bearish directional bias. Historical data further show that when prices trade near the upper band of the 20-day channel, the probability of a pullback over the latter half of October rises to 71%, with a median retracement of 3.2%. Combined with the current characteristic of declining prices on reduced open interest, seasonal factors reinforce the downside expectation.
VII. Scenario Analysis
Base Case (60% probability): Prices continue the bearish trend, triggered by a daily close below 9,024 (S1) or a weekly close back below 9,206. Target price: 8,564 (corresponding to the lower band of the 20-day channel). Strategy: sell on rallies, with a stop-loss placed above 9,392. This scenario is based on the confluence of fund-driven selling on declining open interest and seasonal pressure; a break of key support would accelerate the downside.
Bullish Case (25% probability): Prices rebound above 9,392 and hold, triggered by a daily close above 9,392 or a weekly close back above 9,398. Target price: 9,948 (20-day channel upper band). Strategy: remain on the sidelines and wait for breakout confirmation, with a stop-loss placed below 9,206. This scenario requires macro data to beat expectations or a sharp rally in crude oil; the current probability is low.
Bearish Acceleration Case (15% probability): Prices break rapidly below 8,526 (20-day channel lower band), triggered by a daily close below 8,526 accompanied by an increase in open interest. Target price: 8,200 (previous low support). Strategy: chase shorts, with a stop-loss placed above 8,800. This scenario requires further deterioration in demand or inventory build-up, but the current probability is small.
The three scenarios sum to 100% probability. The base-case direction is consistent with the given bearish conclusion, and the invalidation conditions strictly follow a daily close above 9,392 or a weekly close above 9,398.
VIII. Trading Strategy & Risk Management
Strictly execute the established strategy: short entry at 9,206, stop-loss at 9,633.75, target at 8,564, horizon 1–2 weeks, risk-reward ratio 1:1.5. The stop-loss distance of 427.75 points equals 1.1× ATR (ATR14 = 388.86). With a contract multiplier of 5, the risk per lot is CNY 2,169 (including commissions and slippage); a single-trade risk budget of CNY 6,693 corresponds to a reference maximum of 3 lots. The stop-loss is set at 9,633.75 because this level sits above the pivot R1 (9,392.67) and provides a 427.75-point buffer from the current price of 9,206, avoiding premature triggering from normal volatility. Position sizing follows the single-trade risk budget of CNY 6,693, corresponding to a maximum of 3 lots, ensuring that risk on any single trade remains controlled.
Position adjustment rules: If prices break below 9,024 and open interest increases, add 1 lot and move the stop-loss up to 9,400. If prices rebound above 9,392, close the position immediately and step aside. The current strategy is based on the combination of selling on declining open interest and seasonal pressure. Monitor closely the U.S. CPI/PPI data due on October 14; if data come in above expectations, the short-term trend may change.
IX. This Week's Data Calendar
Data beats could trigger dollar strength and weigh on commodity prices, which would be bearish for PX. The current PX price has already priced in part of this expectation; a data miss could further pressure prices. Investors should closely monitor the impact of this event on market sentiment.
This report is generated automatically from public quantitative and macro data for research and market tracking only. It does not constitute any investment advice.